A new clinical frontier is hybrid sequences. Such synthetic compounds integrate sections derived from various peptide families, allowing the creation of unique therapeutic properties. This strategy offers the exciting https://chimerapeptides945111.thebegoodblog.com/834935/chimera-peptides-a-novel-therapeutic-frontier